Trials / Conditions / Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis (FSGS)
7 registered clinical trials studyying Focal Segmental Glomerulosclerosis (FSGS) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclero NCT07499700 | Bio-Thera Solutions | Phase 2 / Phase 3 |
| Recruiting | SLIT ABS: Study on Patients With Autoimmune Podocytopathy NCT07516964 | Meyer Children's Hospital IRCCS | N/A |
| Completed | Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impai NCT06529796 | Vertex Pharmaceuticals Incorporated | Phase 1 |
| Completed | A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147 NCT05955872 | Vertex Pharmaceuticals Incorporated | Phase 1 |
| Recruiting | Raman Spectroscopy Diagnosis of Kidney Diseases NCT06760845 | Zunsong Wang | — |
| Terminated | A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS) NCT03448692 | Pfizer | Phase 2 |
| Withdrawn | Rituximab Treatment of Focal Segmental Glomerulosclerosis NCT00550342 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |